- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Mobile P.E.T. buys seven GE scanners
Five of seven GE PET Advance scanners purchased by Mobile P.E.T. Systems will travel thousands of miles around the U.S. as systems are placed in Northern and Southern California, Ohio, Florida, and Texas.The two remaining positron emission tomography
Five of seven GE PET Advance scanners purchased by Mobile P.E.T. Systems will travel thousands of miles around the U.S. as systems are placed in Northern and Southern California, Ohio, Florida, and Texas.
The two remaining positron emission tomography units will go to states currently in negotiation with the San Diego-based company, said Jill Janek, Mobile P.E.T. Systems marketing official.
The system going to Texas will serve an area where patients cant reach a PET center unless they drive three hours, said John Relic, CEO of the Austin Radiological Association.
GE Medical Systems introduced its first mobile PET camera at last years RSNA show. Mobile P.E.T. has purchased the machines in a lease financing agreement worth $12 million.
In December of last year, GE placed more than 100 Advance PET systems worldwide. The company expects to double that figure this year, said Beth Klein, general manager of GEs global nuclear/PET business (SCAN 12/15/99).
If Mobile P.E.T. is satisfied with the performance of the Advance, it will consider adding more GE scanners to the fleet, Janek said.
Mobile P.E.T. Systems provides shared PET services to hospitals and other healthcare providers on contract. The firm unveiled its first mobile cardiac unit in March (SCAN 2/28/00). The GE scanners do not measure cardiac activity, Janek said.
New AI-Powered Ultrasound Devices May Enhance Efficiency in Women's Imaging
April 19th 2024One of the features on the new Voluson Signature 20 and 18 ultrasound devices reportedly uses automated AI tools to facilitate a 40 percent reduction in the time it takes to perform second trimester exams.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
